https://www.taxtmi.com/caselaws?id=354631 The tribunal allowed the appeal of the pharmaceutical company, holding that the disallowance of marketing and sales promotion expenses under CBDT Circular No. 5/2012 was unjustified. The tribunal found that the Medical Council of India regulations do not apply to pharmaceutical companies, and the CBDT Circular improperly extended the scope of these regulations. Therefore, the disallowance by the Assessing Officer and confirmation by the CIT(A) were deemed incorrect, resulting in the appeal being allowed in favor of the pharmaceutical company. en-us Mon, 29 Jan 2018 00:00:00 +0530 Thu, 22 Mar 2018 16:30:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=354631 The tribunal allowed the appeal of the pharmaceutical company, holding that the disallowance of marketing and sales promotion expenses under CBDT Circular No. 5/2012 was unjustified. The tribunal found that the Medical Council of India regulations do not apply to pharmaceutical companies, and the CBDT Circular improperly extended the scope of these regulations. Therefore, the disallowance by the Assessing Officer and confirmation by the CIT(A) were deemed incorrect, resulting in the appeal being allowed in favor of the pharmaceutical company. Case-Laws Income Tax Mon, 29 Jan 2018 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=354631